EVOGENE LTD's ticker is EVGN and the CUSIP is M4119S104. A total of 41 filers reported holding EVOGENE LTD in Q3 2021. The put-call ratio across all filers is 1.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,042 | -44.8% | 30,762 | +0.7% | 0.00% | -50.0% |
| Q2 2023 | $32,701 | +111.3% | 30,562 | +24.4% | 0.00% | +100.0% |
| Q1 2023 | $15,474 | -25.2% | 24,562 | -16.9% | 0.00% | -50.0% |
| Q4 2022 | $20,693 | -23.4% | 29,562 | -7.5% | 0.00% | 0.0% |
| Q3 2022 | $27,000 | +12.5% | 31,962 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $24,000 | -48.9% | 31,962 | -12.3% | 0.00% | -50.0% |
| Q1 2022 | $47,000 | -51.0% | 36,462 | +27.0% | 0.00% | -55.6% |
| Q4 2021 | $96,000 | +5.5% | 28,700 | -17.3% | 0.01% | +12.5% |
| Q3 2021 | $91,000 | -5.2% | 34,700 | +20.9% | 0.01% | -11.1% |
| Q2 2021 | $96,000 | -12.7% | 28,700 | +21.1% | 0.01% | -18.2% |
| Q1 2021 | $110,000 | +41.0% | 23,700 | +43.6% | 0.01% | +22.2% |
| Q4 2020 | $78,000 | – | 16,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 293,057 | $481,000 | 0.20% |
| Eidelman Virant Capital | 113,000 | $185,000 | 0.07% |
| Susquehanna International Group Ltd. | 31,753 | $55,000 | 0.02% |
| ARK Investment Management | 3,611,842 | $6,020,000 | 0.02% |
| Senvest Management, LLC | 230,606 | $378,000 | 0.01% |
| Csenge Advisory Group | 28,700 | $96,000 | 0.01% |
| MGO ONE SEVEN LLC | 25,340 | $42,000 | 0.00% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 25,826 | $42,000 | 0.00% |
| SNS Financial Group, LLC | 10,000 | $16,000 | 0.00% |
| Vident Investment Advisory, LLC | 49,786 | $82,000 | 0.00% |